目次
Chapter- 1: Introduction
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update?
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
Chapter- 2: Summary and Highlights
Market Overview
Chapter- 3: Market and Technology Background
Biopharmaceutical Industry Structure
Origins of Biotechnology
Involvement of Large Pharmaceutical Companies
Overview of Biologics
Biologics Manufacturing
Biopharmaceutical Manufacturing Process
FDA Regulation of Biologics
Chapter- 4: Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Figure 2 : Biological Therapeutic Drugs Market Dynamics
Chapter- 5: Market Breakdown by Product Segment
Global Market for Biological Therapeutic Drugs by Product
Chapter- 6: Market Breakdown by Application
Global Market for Biological Therapeutic Drugs by Application
Chapter- 7: Market Breakdown by Source
Global Market for Biological Therapeutic Drugs by Source
Chapter- 8: Market Breakdown by Region
Global Market for Biological Therapeutic Drugs by Region
Chapter- 9: Emerging Technology for Biologics Manufacturing
Introduction
AcceTT & BacSec Technologies
Single-use Technologies
Cell and Gene Therapy (CGT)
Doggybone DNA (dbDNA)
Emerging Biologics Discovery and Generation Technologies
Emerging Trends in Biologic Production Technologies
Example of New Developments by Companies
Chapter- 10: Sustainability in the Biopharmaceuticals and Biologics Industry: An ESG Perspective
Importance of ESG in the Biopharmaceuticals Manufacturing Industry
ESG Ratings and Metrics: Understanding the Data
ESG Practices in the Biopharmaceuticals and Biologics Manufacturing Industry
BCC Research Viewpoint
Chapter- 11: M&A and Venture Funding Outlook
M&A Analysis
Chapter- 12: FDA Approved Monoclonal Antibodies, 1986-2023
Table 47 : U.S. FDA-approved Monoclonal Antibodies in the Market, 2023
Chapter- 13: Competitive Landscape
Porter's Five Forces Analysis
Figure 79 : Global Manufacturer Market Shares of Biological Therapeutics, 2022
Chapter- 14: Company Profiles
ABBVIE INC.
AMGEN INC.
BAXTER INTERNATIONAL INC.
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CSL LTD.
DENDREON PHARMACEUTICALS LLC.
Lilly
F. HOFFMANN-LA ROCHE LTD.
GLAXOSMITHKLINE PLC
GLYCOTOPE GMBH
GRIFOLS S.A.
JSC PHARMSTANDARD
KEDRION S.P.A.
LONZA
MERCK & CO. INC.
NOVARTIS AG
OCTAPHARMA AG
RELIANCE LIFE SCIENCES
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.
